Latest KFF Health News Stories
Journalists Explore Inefficiency and Inequities of Vaccine Rollout
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
KHN’s ‘What the Health?’: Covid and Kids
Can schools safely reopen before all teachers and staffers are vaccinated against covid? And what’s the best way to communicate that science — and scientific recommendations — change and evolve? Also, get ready for a redo of open enrollment for Affordable Care Act coverage, this time with help and outreach to find those eligible. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more.
Hard Bargain: Biden and Congress Agree on Basic Relief, but Chasms Remain on Covid Plan
Agreement between the president and Republican senators on funding for basic public health matters such as vaccine distribution and covid testing was an easy target. That money can’t move out, though, until accord is reached on some of the president’s big-ticket economic plans.
Cien millones de vacunas contra covid en 100 días no nos hará volver a la normalidad
Los epidemiólogos estiman que es necesario inocular al menos al 70% de la población para que se alcance la inmunidad colectiva, para poder frenar la pandemia.
100 Million Covid Shots in 100 Days Doesn’t Get Us Back to Normal
President Joe Biden’s promise to reach this milestone is an important step forward in vaccine rollout. But it is only the beginning of the sweeping vaccination effort required.
With Demand Far Exceeding Supply, It Matters That People Are Jumping the Vaccine Line
When hospital administrators and politicians’ spouses get immunized before people more at risk, it undermines confidence in the system.
Journalists Stay on Top of Rocky Vaccine Rollout
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
States Move Ahead With Canada Drug Importation While Awaiting Signal From Biden
As president, Donald Trump encouraged states to bring in drugs from Canada, where prices are cheaper. It’s not clear if the new administration will follow suit.
KHN’s ‘What the Health?’: The Long Road to Unwinding Trump Health Policies
President Joe Biden signed a pair of health-related executive orders this week that would, among other things, reopen enrollment under the Affordable Care Act and start to reverse former President Donald Trump’s anti-abortion policies. Meanwhile, Congress remains bogged down with taking up the next round of covid-19 relief. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health policy stories of the week they think you should read, too.
Huge Gaps in Vaccine Data Make It Next to Impossible to Know Who Got the Shots
Details about race, ethnicity and occupation are often missing as data collected nationally is scattered across scores of digital systems that don’t connect. And the CDC doesn’t require vaccinators to report occupations of recipients, even though the order in which people get shots largely depends on their job.
Por qué ni siquiera la presión presidencial podría acelerar las vacunas contra covid
Miles de estadounidenses están muriendo a causa de covid-19, pero los esfuerzos para aumentar la producción de vacunas que potencialmente salvan vidas están en un callejón sin salida.
Big Business Boosts Vaccine Effort, but It’s ‘Complex Choreography’ to Get Shots in Arms
Corporations like Starbucks, Honeywell, Microsoft, Costco and Google are lining up to help with vaccine logistics. But the problem of the moment is supply, not systems.
Why Even Presidential Pressure Might Not Get More Vaccine to Market Faster
Even invoking the widely heralded Defense Production Act to pressure drugmakers wouldn’t overcome vast obstacles.
KHN’s ‘What the Health?’: The Biden Health Agenda
President Joe Biden is wasting no time getting to work. On his first day in office, Biden signed a series of executive orders addressing the covid pandemic, promising more to come. But even with Democrats taking the barest majority in the Senate, the new president’s ambitious proposals on covid and other health issues could be in for a rough ride. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health policy stories of the week they think you should read too.
Biden Takes the Reins, Calls for a United Front Against Covid and Other Threats
On health care, President Joe Biden made it clear that combating the covid-19 pandemic will be his top priority. “We must set aside politics and finally face this pandemic as one nation,” he said. “We will get through this together.”
Biden prometió 100 millones de vacunas de covid en 100 días. No será fácil de cumplir
Está en la naturaleza de los presidentes hacer promesas. Kennedy prometió enviar un hombre a la luna y lo cumplió. Distribuir 100 millones de vacunas parece más difícil.
Biden’s Covid Challenge: 100 Million Vaccinations in the First 100 Days. It Won’t Be Easy.
But keeping campaign promises regarding the nation’s covid response will go beyond stepping up the rollout of the vaccines.
Biden Terms Vaccine Rollout ‘A Dismal Failure’ as He Unveils Pandemic Response Plan
President-elect Joe Biden has delivered two speeches within the past 24 hours focused on his ambitious plans to address the “twin crises” of the covid-19 pandemic and its impact on the economy.
Aunque controlen el Senado, demócratas necesitarán apoyo republicano en temas clave de salud
Con el control del Senado y la Cámara de Representantes, tendrán el poder de elegir qué propuestas de salud se votarán en el Congreso. Pero no será tan fácil.
Even With Senate Control, Democrats Will Need Buy-In From GOP on Key Health Priorities
With a majority too small to eliminate the filibuster, Democrats will not have enough votes in the Senate to pass many of their plans without Republicans and will also have only a razor-thin majority in the House. This combination could doom many Democratic health care proposals, like offering Americans a government-sponsored public insurance option, and complicate efforts to pass further pandemic relief.
